We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 101-120 of 1,503 results
  1. From complexity to clarity: unravelling tumor heterogeneity through the lens of tumor microenvironment for innovative cancer therapy

    Despite the tremendous clinical successes recorded in the landscape of cancer therapy, tumor heterogeneity remains a formidable challenge to...

    Sikiru O. Imodoye, Kamoru A. Adedokun, Ibrahim O. Bello in Histochemistry and Cell Biology
    Article 08 January 2024
  2. Nasopharyngeal carcinoma: current views on the tumor microenvironment's impact on drug resistance and clinical outcomes

    The incidence of nasopharyngeal carcinoma (NPC) exhibits significant variations across different ethnic groups and geographical regions, with...

    Huai Liu, Ling Tang, ... Pan Chen in Molecular Cancer
    Article Open access 22 January 2024
  3. MicroRNAs and the Mediterranean diet: a nutri-omics perspective for lung cancer

    Lung cancer is the deadliest cancer type worldwide with ~ 1.8 million deaths per-year. Smoking accounts for ~ 85% of all cases, with a described...

    Roberto Cuttano, Francesco Mazzarelli, ... Elisa Dama in Journal of Translational Medicine
    Article Open access 07 July 2024
  4. FTO-targeted siRNA delivery by MSC-derived exosomes synergistically alleviates dopaminergic neuronal death in Parkinson's disease via m6A-dependent regulation of ATM mRNA

    Background

    Parkinson's disease (PD), characterized by the progressive loss of dopaminergic neurons in the substantia nigra and striatum of brain,...

    Yan Geng, **nyi Long, ... Jie Zan in Journal of Translational Medicine
    Article Open access 22 September 2023
  5. Exosome nanovesicles as potential biomarkers and immune checkpoint signaling modulators in lung cancer microenvironment: recent advances and emerging concepts

    Lung cancer remains the leading cause of cancer-related deaths globally, and the survival rate remains low despite advances in diagnosis and...

    Naushad Ahmad Khan, Mohammad Asim, ... Shahab Uddin in Journal of Experimental & Clinical Cancer Research
    Article Open access 29 August 2023
  6. The Hurdle of Precision Medicine in Cancer Immunotherapy: Personalization Now or Then?

    Moving away from the generic treatment for all cancer, precision medicine provides a targeted therapy based on the different profile presented. Since...
    Joseph Jun Quan Ng, Denise Goh, ... Joe Poh Sheng Yeong in Handbook of Cancer and Immunology
    Living reference work entry 2023
  7. Pathophysiology, diagnosis, and herbal medicine-based therapeutic implication of rheumatoid arthritis: an overview

    Rheumatoid arthritis (RA) stands as an autoimmune disorder characterized by chronic joint inflammation, resulting in profound physiological...

    Charanjit Kaur, Yachana Mishra, ... Murtaza M. Tambuwala in Inflammopharmacology
    Article Open access 25 March 2024
  8. The senescence journey in cancer immunoediting

    Cancer progression is continuously controlled by the immune system which can identify and destroy nascent tumor cells or inhibit metastatic...

    Alessandra Zingoni, Fabrizio Antonangeli, ... Alessandra Soriani in Molecular Cancer
    Article Open access 01 April 2024
  9. Trajectories of immune-related serum proteins and quality of life in patients with pancreatic and other periampullary cancer: the CHAMP study

    Background

    There is still a profound lack of efficient therapeutic strategies against pancreatic and other periampullary adenocarcinoma. Surgery is...

    Sofie Olsson Hau, Maja Svensson, ... Karin Jirström in BMC Cancer
    Article Open access 07 November 2023
  10. Immunoregulatory Bioactive Phytoconstituents: Recent Trends and Future Challenges

    Realizing the indispensable role of the immune system in maintaining the disease-free state, concept of immunomodulation is gaining increased public...
    Sreeharsha Nagaraja, Vandana Gawande, ... Swati Pund in Nutraceuticals and Functional Foods in Immunomodulators
    Chapter 2022
  11. Role of Synbiotics in Inflammatory Lung Diseases

    The microbiome of human gut or lungs is a sophisticated ecology of bacterial strains that inhabits the respiratory and digestive systems. Over the...
    Sumel Ashique, Shubneesh Kumar, ... Afzal Hussain in Synbiotics in Human Health: Biology to Drug Delivery
    Reference work entry 2024
  12. Lung cancer immunotherapy: progress, pitfalls, and promises

    Lung cancer is the primary cause of mortality in the United States and around the globe. Therapeutic options for lung cancer treatment include...

    Aritraa Lahiri, Avik Maji, ... Manash K. Paul in Molecular Cancer
    Article Open access 21 February 2023
  13. The anti-estrogen receptor drug, tamoxifen, is selectively Lethal to P-glycoprotein-expressing Multidrug resistant tumor cells

    Background

    P-glycoprotein (P-gp), a member of the ATP Binding Cassette B1 subfamily (ABCB1), confers resistance to clinically relevant anticancer...

    Rowa Bakadlag, Georgia Limniatis, ... Elias Georges in BMC Cancer
    Article Open access 06 January 2023
  14. Tumor immune contexture is a determinant of anti-CD19 CAR T cell efficacy in large B cell lymphoma

    Axicabtagene ciloleucel (axi-cel) is an anti-CD19 chimeric antigen receptor (CAR) T cell therapy approved for relapsed/refractory large B cell...

    Nathalie Scholler, Regis Perbost, ... Jérôme Galon in Nature Medicine
    Article Open access 29 August 2022
  15. An integrated view of lipid metabolism in ferroptosis revisited via lipidomic analysis

    Ferroptosis is a form of regulated cell death characterized by iron-dependent lipid peroxidation. This process contributes to cellular and tissue...

    Jong Woo Kim, Ji-Yoon Lee, ... Eun-Woo Lee in Experimental & Molecular Medicine
    Article Open access 23 August 2023
  16. HER3 in cancer: from the bench to the bedside

    The HER3 protein, that belongs to the ErbB/HER receptor tyrosine kinase (RTK) family, is expressed in several types of tumors. That fact, together...

    Lucía Gandullo-Sánchez, Alberto Ocaña, Atanasio Pandiella in Journal of Experimental & Clinical Cancer Research
    Article Open access 21 October 2022
  17. Exploiting temporal aspects of cancer immunotherapy

    Many mechanisms underlying an effective immunotherapy-induced antitumour response are transient and critically time dependent. This is equally true...

    Rachael M. Zemek, Valsamo Anagnostou, ... Willem Joost Lesterhuis in Nature Reviews Cancer
    Article 17 June 2024
  18. Histone modifications in drug-resistant cancers: From a cancer stem cell and immune evasion perspective

    The development and immune evasion of cancer stem cells (CSCs) limit the efficacy of currently available anticancer therapies. Recent studies have...

    Ming Li **, Kwang Won Jeong in Experimental & Molecular Medicine
    Article Open access 03 July 2023
  19. Recent applications of quantitative systems pharmacology and machine learning models across diseases

    Quantitative systems pharmacology (QSP) is a quantitative and mechanistic platform describing the phenotypic interaction between drugs, biological...

    Sara Sadat Aghamiri, Rada Amin, Tomáš Helikar in Journal of Pharmacokinetics and Pharmacodynamics
    Article 20 October 2021
  20. Immune Checkpoint Inhibitors as an Armor for Targeted Immunotherapy of Colorectal Cancer

    Recent progress in understanding the interplay between tumor cells and immune cells has given emergence to a new field called immunotherapy. Tumor...
    Smita Kapoor, Yogendra S. Padwad in Colon Cancer Diagnosis and Therapy
    Chapter 2021
Did you find what you were looking for? Share feedback.